DFSTX
Price
$60.62
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Net Assets
19.36B
VSMSX
Price
$530.54
Change
+$2.93 (+0.56%)
Updated
Sep 11 closing price
Net Assets
6.45B
Interact to see
Advertisement

DFSTX vs VSMSX

DFSTX vs VSMSX Comparison Chart in %
View a ticker or compare two or three
VS
DFSTX vs. VSMSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSTX is a StrongBuy and VSMSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSTX has more cash in the bank: 19.4B vs. VSMSX (6.45B). VSMSX pays higher dividends than DFSTX: VSMSX (1.15) vs DFSTX (0.97). DFSTX was incepted earlier than VSMSX: DFSTX (35 years) vs VSMSX (15 years). DFSTX (0.28) is less costly to investors than VSMSX (0.03). VSMSX is a more actively managed with annual turnover of: 22.00 vs. DFSTX (5.00). DFSTX has a lower initial minimum investment than VSMSX: DFSTX (0) vs VSMSX (5000000). VSMSX annual gain was more profitable for investors over the last year : 18.18 vs. DFSTX (17.08). DFSTX return over 5 years is better than : 36.53 vs. VSMSX (32.65).
DFSTXVSMSXDFSTX / VSMSX
Total Expense Ratio0.270.03900%
Annual Report Gross Expense Ratio0.280.03933%
Fund Existence35 years15 years-
Gain YTD16.57218.22191%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.4B6.45B301%
Annual Yield % from dividends0.971.1584%
Returns for 1 year17.0818.1894%
Returns for 3 years53.5547.19113%
Returns for 5 years36.5332.65112%
Returns for 10 years110.94145.9976%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LKQ24.110.48
+2.03%
LKQ Corp
NKSH42.840.36
+0.85%
National Bankshares
PBR21.20-0.18
-0.84%
Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share)
TYRA22.03-1.51
-6.41%
Tyra Biosciences
ACTU1.07-0.08
-6.96%
Actuate Therapeutics Inc